Rhumbline Advisers Cuts Stock Holdings in Masimo Co. (NASDAQ:MASI)

Rhumbline Advisers reduced its holdings in Masimo Co. (NASDAQ:MASI - Free Report) by 2.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 124,373 shares of the medical equipment provider's stock after selling 2,641 shares during the quarter. Rhumbline Advisers owned approximately 0.23% of Masimo worth $20,559,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of MASI. FMR LLC increased its stake in Masimo by 41.2% during the 3rd quarter. FMR LLC now owns 6,756,618 shares of the medical equipment provider's stock valued at $900,860,000 after buying an additional 1,970,883 shares during the period. State Street Corp boosted its position in shares of Masimo by 0.7% during the 3rd quarter. State Street Corp now owns 1,438,814 shares of the medical equipment provider's stock valued at $191,837,000 after purchasing an additional 10,179 shares in the last quarter. Westfield Capital Management Co. LP boosted its position in shares of Masimo by 23.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,394,056 shares of the medical equipment provider's stock valued at $185,869,000 after purchasing an additional 262,370 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Masimo by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 792,886 shares of the medical equipment provider's stock valued at $105,741,000 after purchasing an additional 11,984 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Masimo by 9.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 792,166 shares of the medical equipment provider's stock valued at $105,619,000 after purchasing an additional 70,440 shares in the last quarter. 85.96% of the stock is currently owned by institutional investors.

Masimo Trading Down 4.1 %

MASI traded down $7.25 during trading on Friday, hitting $169.96. The company's stock had a trading volume of 603,597 shares, compared to its average volume of 475,070. The firm has a market capitalization of $9.10 billion, a P/E ratio of 117.21 and a beta of 1.02. Masimo Co. has a twelve month low of $101.61 and a twelve month high of $184.51. The stock's fifty day moving average price is $172.90 and its 200-day moving average price is $151.29. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.

Wall Street Analysts Forecast Growth

Several research analysts have commented on MASI shares. Wells Fargo & Company raised their target price on shares of Masimo from $171.00 to $193.00 and gave the stock an "overweight" rating in a report on Wednesday, December 11th. Stifel Nicolaus reissued a "buy" rating and issued a $190.00 price target (up previously from $170.00) on shares of Masimo in a research report on Friday, November 22nd. Piper Sandler lifted their price target on shares of Masimo from $180.00 to $210.00 and gave the stock an "overweight" rating in a research note on Wednesday, December 18th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a report on Wednesday, January 22nd. Finally, Raymond James boosted their price objective on Masimo from $170.00 to $194.00 and gave the company an "outperform" rating in a research report on Friday, December 27th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $191.40.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.